Niacin for reduction of cardiovascular risk.

Documenti analoghi

• Niacin for reduction of cardiovascular risk.
  di: Landray, M, et al.
  Pubblicazione: (2014)
• Effects of extended-release niacin with laropiprant in high-risk patients.
  di: Landray, M, et al.
  Pubblicazione: (2014)
• The effects of vascular and nonvascular adverse events and of extended-release niacin with laropiprant on health and healthcare costs
  di: Kent, S, et al.
  Pubblicazione: (2016)
• Fluvastatin for reduction of cardiovascular risk in patients with moderate to severe renal insufficiency.
  di: Haynes, R, et al.
  Pubblicazione: (2007)
• Niacin: old habits die hard
  di: Haynes, R, et al.
  Pubblicazione: (2016)